Trastuzumab was shown to offer clinical benefit to patients with her 2-positive metastatic breast cancer, and recent trials have demonstrated highly significant survival benefits to her 2-positive patients when trastuzumab is used in combination with chemotherapy 11 , 12 .
1
—
—